HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COVID-19 Test Kit’s Use Of US FDA Logo With ‘Clinical Trial Number’ Fails Regulatory Test

Executive Summary

Anytime COVID Test marketed home-use test without FDA approval or EUA and promoted it with an FDA logo and a “clinical trial number.” Warning letter says “your presentation conveys the misimpression that the product has been approved, cleared, authorized, endorsed or otherwise evaluated by FDA.”

You may also be interested in...

US FDA Targets Making More COVID-19 Tests Available OTC With EUA Template Changes

Agency changes two of its emergency use authorization templates “to support authorization of more COVID-19 tests” for OTC use and to offer “flexible study recommendations.”

US Marketers Exploiting Growing Probiotics Demand Warned About Disease, Anxiety Claims

FDA warnings indicate marketers are looking to take advantage of growing demand for probiotics with disease treatment claims and also pitching herbal remedies to consumers to alleviate anxiety, depression and insomnia. New York firm offers OTC sales of injectable serums for skin toning. 

These Letters Are Not Tests: US FDA Warns Firms’ OTC Products Are Not Approved COVID-19 Tests

Five firms' “representations create a false impression that [their] products have been authorized for emergency use by FDA and are misleading," states FDA's medical device center. 

Related Content


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts